Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms NW-7-295 |
Target |
Action inhibitors |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Malignant Neoplasm | Discovery | China | 18 Mar 2024 | |
Hematologic Neoplasms | Discovery | United States | - | |
Hematologic Neoplasms | Discovery | China | - |